Skip to content

Effect of transcutaneous vagus nerve stimulation at auricular concha on patients with autism spectrum disorder: a random-controlled trail study

Effect of transcutaneous vagus nerve stimulation at auricular concha on patients with autism spectrum disorders: a random-controlled trail study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012642
Enrollment
Unknown
Registered
2017-09-11
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

t-VNS group:NA
st-VNS group:NA

Sponsors

School of Public Health, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. DSM-5 will be used for the diagnosis of autism spectrum disorders: (1) The main problem is persistent deficits in social communication and social interaction; (2) Restricted, repetitive patterns of behavior, interests, or activities; (3) Symptoms must be present in the early developmental period; (4) Symptoms cause clinically significant impairment in social, occupational, or other important areas of current functioning; (5) These disturbances are not better explained by intellectual disability (intellectual developmental disorder) or global developmental delay. 2. Patients aged between 6-18 years; 3. uncorrected or corrected visual acuity; 4. right-handed; 5. Patients who can understand the content of scales and volunteer to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Mental disease except ASD (such as epilepsy, schizophrenia, mental retardation, etc.); 2. Severe nervous system disease; 3. history of brain injury; 4. other developmental behavior disorders (such as learning disabilities, attention deficit hyperactivity disorder, etc); 5. Severe somatic diseases.

Design outcomes

Primary

MeasureTime frame
Cytokines;magnetic resonance imaging (T1, DTI, rs-fMRI);Autism Treatment Evaluation Checklist;Childhood Autism Rating Scale;Social Responsiveness Scale;

Secondary

MeasureTime frame
The Screen for Child Anxiety Related Emotional Disorders;Child Quality of Life;Neurotransmitters (GABA, NE, 5-HT);Empathizing/Systemizing quotient, child version;The Children's Sleep Habits Questionnaire;Wechsler Intelligence Scale for Children-IV;Psychoeducational Profile-Third Edition;Conners Parent Symptom Questionnaire;behavior teat;

Countries

China

Contacts

Public ContactYu Jin

School of Public Health, Sun Yat-sen University

jinyu@mail.sysu.edu.cn+86 13828487185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026